Skip to main content
Equibles

Eversept Partners, LP

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1697013 NEW YORK, NY
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,698,219
+$1,159,930 QoQ
Shares Held
276,174
0.0% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#25
of 96 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Derivatives in KPTI

reported options exposure · as of Mar 31, 2026
CallValue
$132,566
CallShares
23,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. KPTI ranks #46 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 913,880 $121,783,648
2 VERA
Vera Therapeutics, Inc.
 2,212,770 $94,949,960
3 CLDX
Celldex Therapeutics, Inc.
 1,785,941 $66,454,864
4 SNDX
Syndax Pharmaceuticals Inc
 2,798,210 $61,168,870
5 IONS
Ionis Pharmaceuticals Inc
 664,684 $52,702,794
6 TVTX
Travere Therapeutics, Inc.
 798,973 $45,389,656
7 PCVX
Vaxcyte, Inc.
 629,952 $36,619,109
8 GERN
Geron Corp
 18,717,422 $23,958,300

All Filings in KPTI

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,698,219 276,174
2026-03-31 $132,566 23,800
2026-03-31 $1,538,289 276,174
2025-06-30 $1,108,333 257,154
2025-03-31 $961,755 257,154
2024-12-31 $1,411,999 2,088,757
2024-09-30 $4,604,740 5,547,880
2024-06-30 $4,328,872 4,987,180
2024-03-31 $7,574,643 5,016,320